Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol^®-PM) in patients with solid tumorsLIM, W. T; TAN, E. H; TOH, C. K et al.Annals of oncology. 2010, Vol 21, Num 2, pp 382-388, issn 0923-7534, 7 p.Article

Preparing for first-in-man studies : the challenges for translational immunology post-TGN1412DAYAN, C. M; WRAITH, D. C.Clinical and experimental immunology (Print). 2008, Vol 151, Num 2, pp 231-234, issn 0009-9104, 4 p.Article

Safety issues in cell-based intervention trialsDAWSON, Liza; BATEMAN-HOUSE, Alison S; SCHILL, Kathryn E et al.Fertility and sterility. 2003, Vol 80, Num 5, pp 1077-1085, issn 0015-0282, 9 p.Article

A Phase 1 /Pharmacokinetic Study of Sunitinib in Combination With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Positive Patients With Cancer: AIDS Malignancy Consortium Trial AMC 061RUDEK, Michelle A; MOORE, Page C; HAIGENTZ, Missak et al.Cancer. 2014, Vol 120, Num 8, pp 1194-1202, issn 0008-543X, 9 p.Article

Phase 1 and Pharmacodynamic Trial of Everolimus in Combination With Cetuximab in Patients With Advanced CancerCIUNCI, Christine A; PERINI, Rodolfo F; DIVGI, Chaitanya R et al.Cancer. 2014, Vol 120, Num 1, pp 77-85, issn 0008-543X, 9 p.Article

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumoursBOWLES, D. W; MA, W. W; HAUSMAN, D et al.British journal of cancer. 2013, Vol 109, Num 5, pp 1085-1092, issn 0007-0920, 8 p.Article

Timing of Palliative Care Referral and Symptom Burden in Phase 1 Cancer Patients: A Retrospective Cohort StudyHUI, David; PARSONS, Henrique; NGUYEN, Linh et al.Cancer. 2010, Vol 116, Num 18, pp 4402-4409, issn 0008-543X, 8 p.Article

Do Phase 1 Patients Have Greater Needs for Palliative Care Compared With Other Cancer Patients?FINLAY, Esmé; LU, Hien L; HENDERSON, Hope et al.Cancer. 2009, Vol 115, Num 2, pp 446-453, issn 0008-543X, 8 p.Article

Phase 1 Study of an Oxaliplatin and Etoposide Regimen in Pediatric Patients With Recurrent Solid TumorsMCGREGOR, Lisa M; SPUNT, Sheri L; SANTANA, Victor M et al.Cancer. 2009, Vol 115, Num 3, pp 655-664, issn 0008-543X, 10 p.Article

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursBLAGDEN, S. P; MOLIFE, L. R; HODGE, J. P et al.British journal of cancer. 2008, Vol 98, Num 5, pp 894-899, issn 0007-0920, 6 p.Article

A Phase 1 Trial of 2 Dose Schedules of ABT-510, an Antiangiogenic, Thrombospondin-1-mimetic Peptide, in Patients With Advanced CancerGORDON, Michael S; MENDELSON, David; CARR, Robert et al.Cancer. 2008, Vol 113, Num 12, pp 3420-3429, issn 0008-543X, 10 p.Article

Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignanciesBRAYBROOKE, J. P; BOVEN, E; BATES, N. P et al.Annals of oncology. 2003, Vol 14, Num 6, pp 913-921, issn 0923-7534, 9 p.Article

A Phase 1 Study of Everolimus Plus Docetaxel Plus Cisplatin as Induction Chemotherapy for Patients With Locally and/or Regionally Advanced Head and Neck CancerFURY, Matthew G; SHERMAN, Eric; PFISTER, David G et al.Cancer. 2013, Vol 119, Num 10, pp 1823-1831, issn 0008-543X, 9 p.Article

Ventriculolumbar Perfusion Chemotherapy for the Treatment of Leptomeningeal Carcinomatosis: A Phase I Study With Pharmacokinetic DataGWAK, Ho-Shin; LIM, Hyeong-Seok; SHIRT, Sang-Hoon et al.American journal of clinical oncology. 2013, Vol 36, Num 5, pp 491-499, issn 0277-3732, 9 p.Article

A Phase 1 Dose-Escalation Study of ARRY-520, a Kinesin Spindle Protein Inhibitor, in Patients With Advanced Myeloid LeukemiasJEAN KHOURY, Hanna; GARCIA-MANERO, Guillermo; KARAN, Sharon et al.Cancer. 2012, Vol 118, Num 14, pp 3556-3564, issn 0008-543X, 9 p.Article

A Phase 1 Study of Efatutazone, an Oral Peroxisome Proliferator-Activated Receptor Gamma Agonist, Administered to Patients With Advanced MalignanciesPISHVAIAN, Michael J; MARSHALL, John L; ZAHIR, Hamim et al.Cancer. 2012, Vol 118, Num 21, pp 5403-5413, issn 0008-543X, 11 p.Article

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumoursBOSS, D. S; GLEN, H; SCHELLENS, Jhm et al.British journal of cancer. 2012, Vol 106, Num 10, pp 1598-1604, issn 0007-0920, 7 p.Article

Phase 1 Study of Arsenic Trioxide, High-Dose Cytarabine, and Idarubicin to Down-Regulate Constitutive Signal Transducer and Activator of Transcription 3 Activity in Patients Aged <60 Years With Acute Myeloid LeukemiaWETZLER, Meir; ANDREWS, Chris; BAUMANN, Heinz et al.Cancer. 2011, Vol 117, Num 21, pp 4861-4868, issn 0008-543X, 8 p.Article

Phase 1 and Pharmacokinetic Study of Everolimus, a Mammalian Target of Rapamycin Inhibitor, in Combination With Docetaxel for Recurrent/Refractory Nonsmall Cell Lung CancerRAMALINGAM, Suresh S; HARVEY, R. Donald; HAIAN FU et al.Cancer. 2010, Vol 116, Num 16, pp 3903-3909, issn 0008-543X, 7 p.Article

Pilot Study of Huachansu in Patients With Hepatocellular Carcinoma, Nonsmall-Cell Lung Cancer, or Pancreatic CancerZHIQIANG MENG; PEIYING YANG; CHANG, David Z et al.Cancer. 2009, Vol 115, Num 22, pp 5309-5318, issn 0008-543X, 10 p.Article

Phase 1 Study of XL119, a Rebeccamycin Analog, in Patients With Refractory Hematologic MalignanciesBORTHAKUR, Gautam; ALVARADO, Yesid; RAVANDI-KASHANI, Farhad et al.Cancer. 2008, Vol 113, Num 2, pp 360-366, issn 0008-543X, 7 p.Article

Phase I trial of intravenous IL-4 Pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptorGARLAND, Linda; GITLITZ, Barbara; EBBINGHAUS, Scot et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 4, pp 376-381, issn 1524-9557, 6 p.Article

Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: A pediatric oncology group studyHAYASHI, Robert J; BLANEY, Susan; SULLIVAN, Jim et al.Journal of pediatric hematology/oncology. 2003, Vol 25, Num 7, pp 539-542, issn 1077-4114, 4 p.Article

Dual Inhibition of the Vascular Endothelial Growth Factor Pathway: A Phase 1 Trial Evaluating Bevacizumab and AZD2171 (Cediranib) in Patients With Advanced Solid TumorsHONG, David S; GARRIDO-LAGUNA, Ignacio; YUEJIN WEN et al.Cancer. 2014, Vol 120, Num 14, pp 2164-2173, issn 0008-543X, 10 p.Article

Suggestions From Adolescents, Young Adults, and Parents for Improving Informed Consent in Phase 1 Pediatric Oncology TrialsBAKER, Justin N; LEEK, Angela C; SALAS, Halle showalter et al.Cancer. 2013, Vol 119, Num 23, pp 4154-4161, issn 0008-543X, 8 p.Article